Hydrogels of Solid lipid Nanoparticles of Curcumin Presented by RUCHI CHAWLA ASSISTANT PROFESSOR IIT(BHU), VARANASI 5 th International Conference and Exhibition.

Slides:



Advertisements
Similar presentations
Grinding Aids for Nano-milling using a Stirred Media Mill Center for Particulate & Surfactant Systems (CPaSS) IAB Meeting Columbia University, New York.
Advertisements

A. Laouini 1, 2, C. Charcosset 2, R. G. Holdich 1, G.T. Vladisavljevic 1 Investigation of the Preparation of Monodispersed Liposome Suspensions Using Microsieve.
OPTIMISING MEDICINES DEVELOPMENT
NUR HIDAYAH OMAR SITI HAJAR ABU BAKAR ALIA ZULAIKHA MOHD HANIF NUR HIDAYAH OMAR SITI HAJAR ABU BAKAR ALIA ZULAIKHA MOHD HANIF.
Pharmaceutics 2 & 3 صيدلانيات 2&3 Unit / second semester Transdermal drug delivery system.
Solubility and Dissolution Pharmaceutical Technology.
NIOSOMES.
VINOD P. SHAH, PH.D. SENIOR RESEARCH SCIENTIST OFFICE OF PHARMACEUTICAL SCIENCE CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION Pharmacy.
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
COMPARISON OF BIOAVAILABILITY OF DIFFERENT FORMS OF CURCUMIN USING NON-EVERTED RAT INTESTINAL SAC MODEL.
Robert J Nicolosi - Director MicroFluidics Technology Fair Nanoemulsion Delivery of Pharmaceutical, Nutraceuticals and Cosmeceuticals In vitro and In vivo.
STRUCTURAL EVALUATION OF MATERIALS BASED ON XANTHAN GUM AND LIGNIN Irina Elena Raschip, Maria-Cristina Popescu “Petru Poni” Institute of Macromolecular.
Dosage Form Design Murat Kizaibek. The Need for Dosage Forms.
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Curcumin, the constituent of Curcuma longa, is considered a very promising anticancer agent due to its potent and pleiotropic antineoplastic activity and.
School of Pharmacy PHARMACEUTICS RESEARCH AREAS. PHARMACEUTICS SYMMETRY/SYNERGY Pre-formulation/Formulation Quality ControlDrug Delivery.
Naagarajan Narayanan Vignesh Muthuvijayan* Department of Biotechnology
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
Improving solubility and cellular absorption of Paclitaxel with solid lipid nanoparticles and cyclodextrin Jong-Suep Baek, Jae-Woo So, Ji-Sook Hwang, Cheong-Weon.
Reporter : Chang-Fu Lain Professor: Cheng-Ho Chen Date : 6/11.
SCALABLE PRODUCTION OF POLYMERIC NANOPARTICLES YING LIU ASSISTANT PROFESSOR DEPARTMENT OF CHEMICAL ENGINEERING DEPARTMENT OF BIOPHARMACEUTICAL SCIENCES.
Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Formulation factors By Dr. A. S. Adebayo.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Enteric-coated alendronate sodium solid lipid nanoparticles; a novel formula to overcome barriers for the treatment of osteoporosis By Funded Project.
Liposomes: Formation, preparation, properties and applications
Controlled drug delivery Jonathan O’Dwyer John Rasmussen CHEN 641.
The Use of a Vesicular Delivery System in the Enhancement of Cisplatin Bioavailability Manal M. Alsaadi, Katharine C. Carter and Alexander B. Mullen Strathclyde.
Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences.
Reporter: Wen-Cheng Lin Teacher:Wei-Tung Liao. Outline Introduction Materials Experimental Results and discussion Conclusions.
Abstract Polymeric Porous microspheres are an effective drug delivery mechanism able to control drug release, preventing drug wastage and lowering costs.
1 Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Belgium 2 Laboratory of Analytical Chemistry, CIRM, University of.
Lipophilicity & Permeability 김연수. Chapter 5. Lipophilicity.
The Biopharmaceutical Classification System (BCS)
Introduction What is a Biowaiver?
CHEE 4401 Pathway of Absorption blood endothelium epithelium connective tissue, muscle.
5th International Conference and Exhibition on
Fig.4. (A) Lipoplexes at N/P 2,5 with 0% and 10%PEG in presence of acidic pH. No leakage and no degradation of siRNA when lipoplexes are in acidic environment.
Physiochemical properties of drugs Using the Sirius T3 to make measurements.
Correlation Between the Transdermal Permeation of Ketoprofen and its Solubility in Mixtures of a pH 6.5 Phosphate Buffer and Various Solvents Ref.: Drug.
Characterization of the interaction between Lomefloxacin and Certain Gastro-retentive Polymers Amir Ibrahim Mohamed a, Osama A. A. Ahmed b, Amira Osama.
Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate Ref.: European Journal of Pharmaceutics.
DEVELOPMENT, OPTIMIZATION AND PROCESS VALIDATION OF THE MODIFIED QUASSI EMULSION SOLVENT DIFFUSION METHOD FOR THE PREPARATION OF MICROSPONGES Rishabh Srivastava*,
1/20 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Co-cross-linked chitosan hydrogel as carrier for the local delivery of cisplatin. Liposome inclusion. Maria José Moura 1,2, Maria Helena Gil 2, Maria Margarida.
Composite Polysaccharide Hydrogels
- Pharmaceutical Equivalence Study
LIPOSOMES AS DRUG CARRIERS
The Release Of Curcumin From Alginate Beads In Different Media
Quality by Design (QbD) Approach
Introduction Objective Experimental Results and Discussion
** Laboratório Edol, Produtos Farmacêuticos, S.A.Lisboa, Portugal
FORMULATION AND IN VITRO EVALUATION OF ATORVASTATIN SOLID DISPERSION
Hashem Alsaab*, Rami M. alzhrani, Sai HS. Boddu
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Naofumi Hashimoto, Ph.D. Faculty of Pharmaceutical Sciences
Microemulsion In Drug Delivery Systems
Biopharmaceutic Considerations in Drug Product Design
9th International Congress on Nutrition & Health
Pharmacokinetics: Drug Absorption
Drug Delivery Systems Pharmaceutical technology Petra University.
Structure of solid lipid nanoparticles (SLNs).
Mansi K. Shah August 16, 2015 Drug Delivery Summit, Houston
Biopharmaceutics 4th year
Biopharmaceutics 4th year
Introduction to Pharmacology
Physical Pharmacy lab Lab no. 1: Concentration Expression
Pharmacokinetics: Drug Absorption
Dr. Basavaraj K. Nanjwade M. Pharm, PhD. Department of Pharmaceutics
2016 Enhanced Synthesis and Purification of PEGylated Liposomes for Targeted Drug Delivery Neil Parikh, Steven Roberts, and Nitin Agrawal
Presentation transcript:

Hydrogels of Solid lipid Nanoparticles of Curcumin Presented by RUCHI CHAWLA ASSISTANT PROFESSOR IIT(BHU), VARANASI 5 th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 16-18, 2015 Crowne Plaza, Dubai, UAE

Contents  Introduction  Experimental work  Preparation of SLNs  Analytical Method for Curcumin  Formulation characterization  Summary and conclusion  References

Introduction Hydrogels: Advantages of Hydrogels (Kopecek, 2009): Shape stability and softness similar to that of the soft surrounding tissues Chemical and biochemical stability Absence of extractables High permeability for water-soluble nutrients and metabolites across the biomaterial tissue-interface Convenient handling Easy application Excellent tissue biocompatibility due to their high water content

Curcumin  Yellow spice derived from the roots, rhizome of Curcuma longa  Adaptogen, bio-protectant, anti-bacterial, antioxidant and anti-inflammatory  Chemically it is a mixture of three principal compounds (Strimpakos and Sharma, 2008):  Curcumin (sometimes referred to as curcumin I),  Demethoxycurcumin (curcumin II), and  Bisdemethoxycurcumin (curcumin III)  Limitations:  Poor systemic bioavailability because of poor absorption and rapid systemic elimination via glucuronidation (Aggarwal and Sung, 2009).  Hydrophobic compound with a high partition coefficient of 3.2 and water solubility around 0.6 μg/ml (Kurien et al.,2007 and Patel et al., 2009).

Why Solid lipid Nanoparticles?  Small size  Possibility of controlled rug release  Increased drug stability  High drug pay load  Incorporation of lipophilic and hydrophilic drugs  Biocompatibility  Enhancement of bioavailability of the incorporated drugs (Mehnert and Mader, 2001)  Enhanced penetration of drug into the skin from lipid nanoparticles, occlusion effect and film formation of lipid nanoparticles on the skin  Larger surface area and contact point to adhere to the skin layer than that of microparticle.  SLN can provide benefits of accumulation of drug in the skin strata to various skin diseases such as acne and eczema (Korting et al, 2007).

Experimental Work

Preparation of SLNs of Curcumin by nanoprecipitation method (Chorny et al., 2002) Organic Phase (58.5 ml acetone and 1.5 ml dichloromethane) consisting of 600 mg of stearic acid and 9.0 mg Curcumin Aqueous Phase (120 mL) containing 0.5, 1.0 & 2.0% w/v PVA Evaporation of organic phaseSLNs suspended in aqueous mediumCollection of SLNs Injected slowly with stirring at 1000 rpm Ultracentrifugation at 10,000 x g for 5 min Solvent removal by evaporation room temperature for 24hours

UV spectrophotometric method for Curcumin

Characterization of SLNs

Compatibility studies FT-IR Spectrum of Curcumin + Stearic acid FT-IR Spectrum of Stearic acid FT-IR Spectrum of Curcumin

Particle size and polydispersity of C-SLNs BatchesParticle-SizePoly Dispersity index Batch-1 (0.5 % PVA) nm Batch -2 (0.75 % PVA) nm Batch 3 (1 % PVA) nm Entrapment Efficiency of C-SLNs Batch (n=3)Total Drug content (mg)Free Drug Content (mg) Entrapment efficiency (%EE) (TDC –FDC)/TDC * 100) Batch % Batch % Batch %

Hydrogel preparation S. No.BatchesCarbopol concentration (% w/v) Hydrogel type 1B1B1 0.5Blank gel 2B2B2 1.0Blank gel 3B3B3 2.0Blank gel 4Y1Y1 0.5In-situ hydrogels* 5Y2Y2 1.0In-situ hydrogels* 6Y3Y3 2.0In-situ hydrogels* 7D1D1 0.5Enriched hydrogels ^ (1:1 ratio of B 2 and C-SLNs # ) 8D2D2 0.66Enriched hydrogels (1:1 ratio of B 2 and C-SLNs # ) *In situ hydrogels were prepared by adding carbopol (0.5, 1.0 and 2.0 %) to fixed volume of C-SLNs suspension containing 1% PVA ^Enriched hydrogels were prepared by adding carbopol hydrogel (1%w/v) to # C-SLNs prepared using 1% PVA

Texture profile analysis Typical force-time plot of Texture analysis

Texture analysis of blank hydrogels

Texture analysis of In-situ hydrogels

Texture analysis of Enriched hydrogels

Comparative Texture analysis

 Conducted using Franz diffusion cells and dialysis membrane  Dissolution media: phosphate buffer pH 6.0 solution containing 1% v/v Methanol maintained at 37 ± 1 ◦C on a magnetic hot plate with moderate stirring In-vitro release studies

In-vitro occlusion test

Summary & Conclusion  Curcumin loaded SLNs were prepared by nano-precipitation technique using stearic acid as lipid and PVA as surfactant.  Batch-3 (1% PVA) exhibited particle size of nm, PDI of and % Entrapment efficiency 82.73%  In vitro release from C-SLN enriched hydrogel showed controlled release of drug in comparison to C-SLNs upto 72 hr with approx.58 % release within 24 hours.  Occlusion test showed reduced water loss from carbopol and even lesser from enriched hydrogel.  Stability studies over a period of 90 days, showed increase in firmness, cohesiveness and index of viscosity and decrease in consistency.  In-situ hydrogels exhibited a concentration (carbopol) dependent increase in firmness, consistency, cohesiveness and viscosity, however, presence of C-SLNs significantly decreased (p < 0.05) these values in comparison to blank hydrogels.  Similar observations were made in enriched hydrogels  Also, a significant difference (p < 0.05) in hydrogel properties was observed between in-situ and enriched hydrogels indicating effect of SLNs on the swelling properties of Carbopol.  Occlusive properties of in-situ hydrogels were better than enriched and blank hydrogels.  In-situ hydrogels also exhibited uniform and extended release of curcumin, alongwith higher permeation characteristics.  Better formulation characteristics of in-situ hydrogels might be because of homogenous deposition and gelling of carbopol around curcumin nanoparticles.

References:  Strimpakos, A. S., Sharma, R. A. (2008). Comprehensive invited review curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants & Redox Signaling 10,  Kurien, B. T., Singh, A., Matsumoto, H., Scofield, R. H. (2007). Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay and Drug Development Technologies 5,  Patel, R., Singh, S. K., Singh, S., Sheth, N.R., Gendle, R. (2009). Development and characterization of curcumin loaded transfersome for transdermal delivery. Journal of Pharmaceutical Sciences and Research 1,  Aggarwal, B. B., Sung, B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences 30,  Mehnert, W. and Mader, K. (2001) Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Deliv. Rev., 47,  Yang, S., Zhu, J., Lu, Y., Liang, B., Yang C. (1999) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res., 16, pp. 751–757.  Korting, M.S., Mehnert, W. and Korting, H.C. (2007) lipid nanoparticles for improved topical applicationof drugs for skin disease, Adv Drug Del Review, 59,  Chorny, M., Fishbein, I., Danenberg, H.D., Golomb, G. (2002) Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics Journal of Controlled Release –400.

23

Thank You